Canada receiving check
Canadian commercial buyers should identify the importer and the exact product's Canadian regulatory status.
Preparing a medicine enquiry from India for Canada? Start with the active ingredient, strength, dosage form, manufacturer and pack. Review the exact product, receiving-party permissions and documentation needs, then identify the receiving person or organisation and intended use before discussing available documents and shipment handling.
Canadian commercial buyers should identify the importer and the exact product's Canadian regulatory status.
Branded and generic medicines across relevant therapeutic categories, with product information and quotation support.
Invoice, packing information, manufacturer details, COA or COO support where applicable and available.
Start with your buyer type and the exact medicine. The relevant receiving route must be checked for each request.
Discuss the exact medicine and proposed personal-treatment route with your clinician or local pharmacy and Health Canada. Confirm whether the route is permitted and which product-specific prescription or authorisation documents are required before planning a shipment. Individual needs do not establish permission for resale.
Canadian commercial buyers should identify the importer and the exact product's Canadian regulatory status. Health Canada's GUI-0117 distinguishes commercial imports from personal-use shipments and sets out product authorisation and establishment requirements. Share the product name, strength, form, pack and intended receiving route; a medicine listed in an overseas catalogue is not automatically authorised for sale in Canada.
Include the product, strength, dosage form, pack size, quantity, destination and intended use. Available product documents and handling requirements can then be discussed.
Official destination guidance
Canadian commercial buyers should identify the importer and the exact product's Canadian regulatory status. Health Canada's GUI-0117 distinguishes commercial imports from personal-use shipments and sets out product authorisation and establishment requirements. Share the product name, strength, form, pack and intended receiving route; a medicine listed in an overseas catalogue is not automatically authorised for sale in Canada. Official import guidance.
Share the receiving organisation or buyer, postal destination and intended use. Confirm the applicable receiving route before requesting shipment coordination.
Buyers can also review support pages for bulk enquiries, hospital supply, cold-chain medicines, specialty sourcing and pharmaceutical documentation.
Buyers can browse category-specific enquiry pages for relevant products, strengths and pack sizes.
Individuals, importers, pharmacies, clinics, hospitals and procurement teams may send product enquiries for review. Acceptance of an enquiry does not confirm medicine availability, permission to supply or import eligibility.
Discuss the exact medicine and proposed personal-treatment route with your clinician or local pharmacy and Health Canada. Confirm whether the route is permitted and which product-specific prescription or authorisation documents are required before planning a shipment. Individual needs do not establish permission for resale.
Canadian commercial buyers should identify the importer and the exact product's Canadian regulatory status. Health Canada's GUI-0117 distinguishes commercial imports from personal-use shipments and sets out product authorisation and establishment requirements. Share the product name, strength, form, pack and intended receiving route; a medicine listed in an overseas catalogue is not automatically authorised for sale in Canada.
State the medicine or active ingredient, strength, dosage form, pack size, quantity, destination and buyer type. The team can then discuss product information and available documentation. Do not send medical histories or identity documents in an initial general enquiry.
No. Product availability and price do not establish permission to supply or import. The applicable receiving route and product requirements must be confirmed before shipment is arranged.
Check the applicable Drug Identification Number, importer establishment licence and foreign-site requirements with the Canadian importer. Any exceptional access route must be verified for the individual request; it is not a general alternative to the commercial requirements.